PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc. announced today that three oral presentations and four poster presentations will be made about the Company’s PET imaging programs in three focus areas – Alzheimer’s disease (AD), Parkinson’s disease (PD) and diabetes – at the upcoming 56th Annual Society of Nuclear Medicine (SNM) meeting in Toronto, Canada, beginning June 13, 2009.
